Table 4_Predictive value of the C-reactive protein-to-lymphocyte ratio for prognosis in he

1605 patient records from the MIMIC-IV database were used to investigate the C-reactive protein-to-lymphocyte ratio (CLR) as a prognostic biomarker. The study by Supei Yin, last updated in May 2026, found higher CLR quartiles were significantly associated with increased 30-day and 365-day all-cause mortality. The dataset likely contains patient identifiers, CLR values, mortality outcomes, and covariates used for Cox regression and Kaplan-Meier analysis.

Use Cases

• Predicting short-term (30-day) mortality risk based on the C-reactive protein-to-lymphocyte ratio (CLR).
• Modeling long-term (365-day) survival outcomes for heart failure patients with acute kidney injury.
• Conducting subgroup analyses to identify potential effect modifiers for the CLR-mortality relationship.
• Benchmarking the discriminative performance (AUC) of CLR against other prognostic biomarkers.

Strengths

• Dataset is derived from the MIMIC-IV database, a known source of critical care patient data.
• Analysis includes results for 1605 patients, providing a specific cohort size.
• Statistical results are detailed, including hazard ratios, p-values, and AUC scores for model performance.

Limitations

• The actual data table with columns and rows is not visible in the provided metadata; structure must be inferred from the description.
• Row count is unknown, which may limit suitability assessment.
• The primary file is a DOCX document (19.0 KB), suggesting the data may be presented in summary tables rather than a raw, analyzable format.

Provenance

Source

MIMIC-IV database

Collection Method

Retrospective cohort study identifying patients with both congestive heart failure and acute kidney injury.

Freshness

Last updated 2026-05-19 04:19:10; freshness should be verified.